Genome British Columbia
Overview
Genome British Columbia is a not-for-profit organization that invests in and supports world-class genomics research and innovation to address challenges and grow the life sciences sectors in British Columbia. It focuses on key areas such as health, forestry, fisheries, aquaculture, agrifood, energy, mining, and the environment. The organization acts as a catalyst, partnering with government, academia, and industry to translate research into applications that generate social and economic benefits. It also works to integrate genomics into society through public engagement and educational initiatives.
Portfolio Companies
14
Website
genomebc.caInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| CuePath Innovation | Nov 2017 | Seed | Co-investor |
| Arbutus Medical Inc. | Feb 2026 | Growth Equity | Co-investor |
| Maia Farms | Sep 2025 | Grant | Lead |
| Sonic Incytes Medical Corp. | May 2020 | Seed | Co-investor |
| Integrated Nanotherapeutics | Mar 2026 | Grant | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Genome British Columbia based?
Genome British Columbia is headquartered in Vancouver, British Columbia, Canada.
When was Genome British Columbia founded?
Founding year information for Genome British Columbia is not publicly available.
How many portfolio companies does Genome British Columbia have?
Genome British Columbia has 14 portfolio companies in Caplight's dataset.
What are some companies in Genome British Columbia's portfolio?
Portfolio companies visible on Caplight include CuePath Innovation, Arbutus Medical Inc., Maia Farms, Sonic Incytes Medical Corp., Integrated Nanotherapeutics.
What was Genome British Columbia's most recent investment shown here?
Genome British Columbia's most recent investment in this portfolio sample was in Integrated Nanotherapeutics in 2026.
What sectors does Genome British Columbia focus on?
Genome British Columbia focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Energy & Sustainability, Consumer & Commerce, Frontier & Industrial Tech, Frontier & Industrial Tech, Healthcare & Life Sciences, Healthcare & Life Sciences, Energy & Sustainability, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, Energy & Sustainability, Enterprise Software, Frontier & Industrial Tech, Enterprise Software, Frontier & Industrial Tech.
What company stages does Genome British Columbia focus on?
Genome British Columbia typically invests at the MultiStage stage.